Login
Get Started
Today
Browse
Screens
Folios
Discuss
Learn
Browse
Shares
Healthcare
Biotechnology & Medical Research
Asarina Pharma AB (publ)
ASAP -
Asarina Pharma AB (publ)
Reuters News
SEK6.78
0.0 0.0%
Last Trade -
2:04pm
Sector
Healthcare
RiskRating
Highly Speculative
Size
Micro Cap
Style
Sucker Stock
Market Cap
£10.8m
Enterprise Value
£5.84m
Revenue
£n/a
Position in Universe
1552nd / 1829
Quality
Value
Momentum
Stock
Rank™
StockReport™
Tools
Compare with...
Run through checklist
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
Charts
News
Discussions
ASAP Dividends
Reuters News
All News
Reuters News
Company Announcements
BRIEF-Asarina Pharma AB (Publ) - Q4 Operating Loss 23.6 Sek Million
25th Feb
News
BRIEF-Asarina Pharma: Preclinical Study Shows Sepranolone Suppresses Tics In Tourette Syndrome
12th Feb
News
BRIEF-Asarina Pharma Q3 Operating Loss Narrows To SEK 17.5 Mln
25th Nov '20
News
BRIEF-Asarina Pharma Q2 Operating Loss Narrows To SEK 17.8 Million
19th Aug '20
News
BRIEF-Asarina Pharma Q1 Operating Loss Widens To SEK 21.1 Mln
26th May '20
News
BRIEF-Asarina Pharma Reports Topline Results From Study In PMDD
22nd Apr '20
News
BRIEF-Asarina Pharma Q4 Operating Loss Narrows To SEK 19.5 Mln
21st Feb '20
News
BRIEF-Asarina Pharma Q3 Operating Loss Widens To SEK 21.8 Mln
20th Nov '19
News
BRIEF-Karolinska Development Divests Ownership In Asarina Pharma
28th Oct '19
News
BRIEF-Asarina Pharma Completes Directed Share Issue Of About SEK 48 Mln
24th Oct '19
News
BRIEF-Asarina Pharma April-June Net Loss Widens To SEK 25.8 Mln
20th Aug '19
News
BRIEF-Asarina Pharma Receives FDA IND Approval For Sepranolone
9th Jul '19
News
BRIEF-Asarina Pharma Issues New Shares To Ergomed PLC
3rd Jun '19
News
BRIEF-Asarina Pharma Q1 Operating Loss Widens To SEK 10.8 Million
20th May '19
News
BRIEF-Asarina Pharma Shows Efficacy Of Sepranolone In Tourette's Syndrome
2nd Apr '19
News
BRIEF-Asarina Pharma Q4 Operating Loss Widens To SEK 20.5 Mln
25th Feb '19
News
BRIEF-Asarina Pharma Q3 Operating Loss Widens To SEK 14.6 Mln
14th Nov '18
News
BRIEF-Asarina Pharma Over-Allotment Option Fully Exercised
24th Oct '18
News
Discover the metrics influencing Asarina Pharma AB (publ)'s share price
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email
© Stockopedia 2021, Refinitiv, Share Data Services.
Facebook
Twitter
Youtube
Instagram
RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our
Terms of Use
,
Privacy
and
Disclaimer
policies.
Discover the metrics influencing Asarina Pharma AB (publ)'s share price
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email